Cosep, Kyra Kloe A.
HRN: 21-34-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2022
AMPICILLIN 250MG (VIAL)
05/25/2022
05/31/2022
IV DRIP
250 Mg
Q12h
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes